Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Xavier Masramon"'
Autor:
Stephen Winchester, Alex Castellarnau, Kashif Jabbar, Meera Nadir, Kapila Ranasinghe, Xavier Masramon, George R. Kinghorn, Isaac John, Jeremy R. A. Paull
Publikováno v:
Pharmaceutics, Vol 16, Iss 9, p 1173 (2024)
Background/Objectives: Dendrimer-based astodrimer sodium nasal spray was assessed for its ability to reduce SARS-CoV-2 load in outpatients with COVID-19, which remains a severe illness for vulnerable groups. Methods: This was a randomised, double-bli
Externí odkaz:
https://doaj.org/article/8328b88d31f24c06a1dcb7cc099e0bf0
Autor:
Adelaide A. Hebert, MD, Theodore Rosen, MD, Núria Albareda López, BS, Ilonka Zsolt, MD, PhD, Xavier Masramon
Publikováno v:
International Journal of Women's Dermatology, Vol 6, Iss 2, Pp 109-115 (2020)
Background: Ozenoxacin is a topical antibiotic approved in the United States for treatment of impetigo in adults and children age ≥2 months. This analysis evaluated the efficacy and safety of ozenoxacin in specific pediatric age groups. Methods: Da
Externí odkaz:
https://doaj.org/article/ac0ce70512e54d93a9be7c44aefc7a84
Publikováno v:
International Journal of Women's Dermatology, Vol 6, Iss 2, Pp 109-115 (2020)
International Journal of Women's Dermatology
International Journal of Women's Dermatology
Background: Ozenoxacin is a topical antibiotic approved in the United States for treatment of impetigo in adults and children age ≥2 months. This analysis evaluated the efficacy and safety of ozenoxacin in specific pediatric age groups. Methods: Da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9d86df643b6b39941e55bd8589bfc8
http://www.sciencedirect.com/science/article/pii/S2352647519301169
http://www.sciencedirect.com/science/article/pii/S2352647519301169
Autor:
Herman Buschke, Faustino Diéguez-Vide, Jordi Peña-Casanova, Xavier Masramon, Gonzalo Sánchez-Benavides, Juan Domingo Gispert, Karine Fauria, Nina Gramunt, José Luis Molinuevo
Publikováno v:
Journal of Alzheimer's Disease. 52:283-293
BACKGROUND The Memory Binding Test (MBT) is emerging as a promising tool for the detection of subtle memory impairment suggestive of Alzheimer's disease (AD). For such a test to be widely accessed and used, the availability of both alternate forms an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09de8fd84725930b6cae3d7fee597ec0
https://doi.org/10.3233/jad-151175
https://doi.org/10.3233/jad-151175
Autor:
Adelaide A, Hebert, Nuria, Albareda, Theodore, Rosen, Antonio, Torrelo, Ramon, Grimalt, Noah, Rosenberg, Ilonka, Zsolt, Xavier, Masramon
Publikováno v:
Journal of drugs in dermatology : JDD. 17(10)
Ozenoxacin is a novel topical antibacterial agent with potent bactericidal activity against Gram-positive bacteria that has been developed as a 1% cream for treatment of impetigo. This article presents pooled results of pivotal clinical trials of oze
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a08cba2df987fcbfef25aa6163d682af
https://pubmed.ncbi.nlm.nih.gov/30365584
https://pubmed.ncbi.nlm.nih.gov/30365584
Autor:
Xavier Masramon, José M. Miralles-García, Lucio Cabrerizo, Cristina Comi-Diaz, Pedro de Pablos-Velasco, María Pérez
Publikováno v:
Endocrinología y Nutrición. 57:472-478
Objective To determine the degree of control of cardiovascular risk factors (CVRF) in a sample of patients with diabetes mellitus (DM) attending Endocrinology and Nutrition Departments in Spain. Material and methods An epidemiological, cross-sectiona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49d03643333db0084779cb716f84c9ff
https://doi.org/10.1016/j.endonu.2010.09.003
https://doi.org/10.1016/j.endonu.2010.09.003
Autor:
Winchester, Stephen1 (AUTHOR) s.winchester@nhs.net, Castellarnau, Alex2 (AUTHOR) alex.castellarnau@starpharma.com, Jabbar, Kashif3 (AUTHOR) kashif.jabbar@nhs.net, Nadir, Meera3 (AUTHOR) meera.nadir@nhs.net, Ranasinghe, Kapila3 (AUTHOR) kapila.ranasinghe@nhs.net, Masramon, Xavier4 (AUTHOR) xavier.masramon@sail-biometria.com, Kinghorn, George R.5 (AUTHOR) g.r.kinghorn@sheffield.ac.uk, John, Isaac3,6 (AUTHOR) isaac.john@nhs.net, Paull, Jeremy R. A.2 (AUTHOR) jeremy.paull@starpharma.com
Publikováno v:
Pharmaceutics. Sep2024, Vol. 16 Issue 9, p1173. 18p.
Autor:
Luis Miguel Blanco-Colio, Gian Franco Gensini, Jesús Egido, Csaba Farsang, Allan Gaw, Lawrence A. Leiter, José Luis Martín-Ventura, Eduardo de Teresa, Anatoly Langer, Xavier Masramon, Carmen Gomez-Guerrero
Publikováno v:
European Journal of Pharmacology. 586:259-265
Adiponectin can suppress atherogenesis by inhibiting the adherence of monocytes, reducing their phagocytic activity, and suppressing the accumulation of modified lipoproteins in the vascular wall. Contradictory data have been reported about the effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f141ca579a339964c4606b82197cbd75
https://doi.org/10.1016/j.ejphar.2008.02.042
https://doi.org/10.1016/j.ejphar.2008.02.042
Autor:
Gonzalo Sánchez-Benavides, Herman Buschke, Faustino Diéguez-Vide, Juan Domingo Gispert, Xavier Masramon, Nina Gramunt, Jordi Peña-Casanova, Richard B. Lipton, Karine Fauria, Jordi Camí, José Luis Molinuevo
Publikováno v:
Journal of Alzheimer's disease : JAD. 48(3)
Background: The Memory Binding Test (MBT) is a novel test based on the learning of two lists of words, developed to detect early memory impairment suggestive of Alzheimer’s disease (AD). Objective: To present and provide reference data of the Spani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d54e712253afea83e57288cb0e1b56e6
https://pubmed.ncbi.nlm.nih.gov/26402091
https://pubmed.ncbi.nlm.nih.gov/26402091
Autor:
Katia Verger, Francesc Colom, Anabel Martínez-Arán, Xavier Masramon, Jose Manuel Goikolea, Eduard Vieta, José Sánchez-Moreno, Mercè Comes
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
Objective To conduct the first randomized, controlled trial assessing the prophylactic efficacy of gabapentin in bipolar disorder. Method We conducted a 1-year, double-blind, randomized, comparative, placebo-controlled, parallel-group, multicenter st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f22d1ab6284c3f814d5213e21a732191
https://doi.org/10.4088/jcp.v67n0320
https://doi.org/10.4088/jcp.v67n0320